$KMFG
KEEMO Fashion Group Ltd

2024 Q2 Form 10-Q Financial Statement

#000149315224023399 Filed on June 11, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q3
Revenue $4.942K $5.100K
YoY Change -1.0% 2.0%
Cost Of Revenue $2.532K $2.523K
YoY Change -3.4% 10.08%
Gross Profit $2.410K $2.577K
YoY Change 1.64% -4.84%
Gross Profit Margin 48.77% 50.53%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit -$4.472K -$2.160K
YoY Change 59.37% -68.27%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$4.472K
YoY Change 59.37%
Income Tax
% Of Pretax Income
Net Earnings -$4.472K -$2.160K
YoY Change 59.37% -68.27%
Net Earnings / Revenue -90.49% -42.35%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 5.500M shares 5.500M shares
Diluted Shares Outstanding 5.500M shares 5.500M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $25.38K $12.00K $28.74K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $4.994K $2.532K $3.405K
Prepaid Expenses $562.00 $1.686K $3.933K
Receivables $6.954K
Other Receivables
Total Short-Term Assets $30.93K $16.22K $43.04K
YoY Change 60.51% 109.07%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $30.93K $16.22K $43.04K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $30.93K $16.22K $43.04K
YoY Change 60.51% -28.01% 109.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $66.90K $40.41K
YoY Change 569.97%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $70.10K $50.92K $49.71K
YoY Change 49.78% 48.12%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $70.10K $50.92K $49.71K
Total Long-Term Liabilities
Total Liabilities $70.10K $50.92K $49.71K
YoY Change 49.78% 48.12%
SHAREHOLDERS EQUITY
Retained Earnings -$71.27K -$66.80K -$38.77K
YoY Change 128.92% 133.92%
Common Stock $5.500K $5.500K $5.500K
YoY Change 52.78% 52.78%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$39.17K -$34.70K -$6.670K
YoY Change
Total Liabilities & Shareholders Equity $30.93K $16.22K $43.04K
YoY Change 60.51% 109.07%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q3
OPERATING ACTIVITIES
Net Income -$4.472K -$2.160K
YoY Change 59.37% -68.27%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
usd
CY2024Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
usd
dei Entity Central Index Key
EntityCentralIndexKey
0001935033
CY2023Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
CY2024Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2023Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
usd
CY2024Q2 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
usd
CY2023Q2 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
usd
CY2024Q2 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
usd
CY2023Q2 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
us-gaap Segment Expenditure Addition To Long Lived Assets
SegmentExpenditureAdditionToLongLivedAssets
usd
us-gaap Segment Expenditure Addition To Long Lived Assets
SegmentExpenditureAdditionToLongLivedAssets
usd
us-gaap Segment Expenditure Addition To Long Lived Assets
SegmentExpenditureAdditionToLongLivedAssets
usd
us-gaap Segment Expenditure Addition To Long Lived Assets
SegmentExpenditureAdditionToLongLivedAssets
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-04-30
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5500000 shares
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
25378 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6954 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
4994 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
3405 usd
CY2024Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
562 usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
3933 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
30934 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
43035 usd
CY2024Q2 us-gaap Assets
Assets
30934 usd
CY2023Q3 us-gaap Assets
Assets
43035 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
66903 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
40405 usd
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3200 usd
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
9300 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
70103 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
49705 usd
CY2024Q2 us-gaap Liabilities
Liabilities
70103 usd
CY2023Q3 us-gaap Liabilities
Liabilities
49705 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5500000 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5500000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5500000 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5500000 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
5500 usd
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
5500 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
26600 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
26600 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-71269 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-38770 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-39169 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-6670 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
30934 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
43035 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4942 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4992 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16558 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9992 usd
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
2532 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
2621 usd
us-gaap Cost Of Revenue
CostOfRevenue
8461 usd
us-gaap Cost Of Revenue
CostOfRevenue
4913 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
2410 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
2371 usd
us-gaap Gross Profit
GrossProfit
8097 usd
us-gaap Gross Profit
GrossProfit
5079 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6882 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5177 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
40596 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19638 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4472 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2806 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-32499 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-14559 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4472 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2806 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-32499 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-2806 usd
us-gaap Net Income Loss
NetIncomeLoss
-32499 usd
us-gaap Net Income Loss
NetIncomeLoss
-14559 usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4472 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2806 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-32499 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14559 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-14559 usd
CY2023Q2 us-gaap Assets
Assets
19272 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16558 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5500000 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5500000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3600000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3600000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5500000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5500000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3600000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3600000 shares
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-6670 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-25867 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-32537 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-34697 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-4472 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-39169 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-12974 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-4945 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-17919 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-6808 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-24727 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-24727 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-2806 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-27533 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-27533 usd
us-gaap Net Income Loss
NetIncomeLoss
-32499 usd
us-gaap Net Income Loss
NetIncomeLoss
-14559 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-6954 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4992 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1589 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4693 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-3371 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
9986 usd
us-gaap Increase Decrease In Due To Other Related Parties
IncreaseDecreaseInDueToOtherRelatedParties
26498 usd
us-gaap Increase Decrease In Due To Other Related Parties
IncreaseDecreaseInDueToOtherRelatedParties
4661 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-6100 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-1400 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3365 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10997 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3365 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-10997 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28743 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18080 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25378 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7083 usd
us-gaap Cost Of Revenue
CostOfRevenue
8461 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
40596 usd
CY2024Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
562 usd
CY2023Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
3933 usd
CY2024Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
562 usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
3933 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-32499 usd
CY2024Q2 us-gaap Assets
Assets
30934 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9992 usd
us-gaap Cost Of Revenue
CostOfRevenue
4913 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19638 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-14559 usd
CY2023Q2 us-gaap Assets
Assets
19272 usd
us-gaap Net Income Loss
NetIncomeLoss
-32499 usd
CY2024Q2 KFGL Working Capital
WorkingCapital
39169 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-39169 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84F_eus-gaap--UseOfEstimates_zt5esy3BpMO8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_869_zmwmLek7GDKi">Use of Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management uses estimates and assumptions in preparing these financial statements in accordance with US GAAP. Those estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities in the balance sheets, and the reported revenue and expenses during the periods reported. Actual results may differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16558 usd
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
us-gaap Cost Of Revenue
CostOfRevenue
8461 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
40596 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-32499 usd
CY2024Q2 us-gaap Assets
Assets
30934 usd
CY2024Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
4994 usd
CY2023Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3405 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
4994 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
3405 usd
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3200 usd
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
9300 usd
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3200 usd
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
9300 usd
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5500000 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5500000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5500000 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5500000 shares
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9992 usd
us-gaap Cost Of Revenue
CostOfRevenue
4913 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19638 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-32499 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-14559 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-32499 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14559 usd
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2024Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
32499 usd
us-gaap Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
The NOL carryforwards begin to expire in 2043
CY2024Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
6825 usd
CY2024Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
6825 usd
CY2023Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
8142 usd
CY2024Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
6825 usd
CY2023Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
8142 usd
CY2024Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
6825 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4942 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4992 usd
CY2024Q2 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1 pure
CY2023Q2 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1 pure
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4992 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16558 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9992 usd
us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1 pure
us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1 pure
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4992 usd
us-gaap Cost Of Revenue
CostOfRevenue
8461 usd
us-gaap Cost Of Revenue
CostOfRevenue
4913 usd
us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1 pure
us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1 pure

Files In Submission

Name View Source Status
0001493152-24-023399-index-headers.html Edgar Link pending
0001493152-24-023399-index.html Edgar Link pending
0001493152-24-023399.txt Edgar Link pending
0001493152-24-023399-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
kfgl-20240430.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
form10-q_htm.xml Edgar Link completed
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
kfgl-20240430_cal.xml Edgar Link unprocessable
kfgl-20240430_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
kfgl-20240430_def.xml Edgar Link unprocessable
kfgl-20240430_lab.xml Edgar Link unprocessable